Effects on physical activity, physical fitness and well-being in a 36-months randomized controlled study, comparing a multimodal hospital-based intervention programme for primary cardiovascular prevention with usual care.


Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
25 Apr 2024
Historique:
received: 24 10 2023
accepted: 15 04 2024
medline: 26 4 2024
pubmed: 26 4 2024
entrez: 25 4 2024
Statut: epublish

Résumé

Cardiovascular disease is a major cause of mortality and morbidity worldwide, and primary prevention efforts are poorly developed in people at high cardiovascular risk. On this background, we performed the Hjerteløftet Study and demonstrated that participation over 36 months in a multimodal primary prevention programme, significantly reduced validated cardiovascular risk scores. In the current substudy we aimed to further explore several elements and effects following the intervention programme. A random sample from the original Hjerteløftet Study was included for further examinations (n = 255, 40% women), and these patients were already randomized to an intervention group (IG) (n = 127), or a control group (CG) (n = 128). We compared changes from baseline to 36-months follow-up in physical activity, cardiorespiratory fitness, psychological well-being (WHO-5), cardiovascular medication use, smoking habits, and cardiometabolic risk factors (blood pressure, lipids, blood glucose, HbA1c, Apolipoprotein A-I, Apolipoprotein B and high-sensitive C-reactive protein). Self-reported physical activity increased significantly with absolute difference in mean delta Physical Activity Index score in the IG compared to the CG: 0.90, 95% CI: 0.10 to 1.70, p = 0.028 (ANCOVA). There were no corresponding differences in cardiorespiratory fitness. The participation resulted in psychological well-being improvement in both groups with a larger increase in the IG compared to the CG. The mean difference in delta WHO-5 score was 5.06, 95% CI: 0.68 to 9.45, p = 0.024, and 3.28, 95% CI: -0.69 to 5.25, p = 0.104 when controlled for baseline values (ANCOVA). The use of antihypertensive medication increased significantly more in the CG (p = 0.044). Only minor, nonsignificant changes were observed for traditional risk factors and cardiometabolic variables. Participation in the Hjerteløftet Study intervention programme resulted in an improved physical activity level, but without changing cardiorespiratory fitness. Participation in the programme also tended to improve psychological well-being, possibly related to increased physical activity, less smoking and less use of cardiovascular medication. Concerning the metabolic status, no major differences were observed, but minor changes may have been concealed by a larger increase in cardiovascular medication use in the control group. ClinicalTrials.gov (NCT01741428), 04/12/2012.

Sections du résumé

BACKGROUND BACKGROUND
Cardiovascular disease is a major cause of mortality and morbidity worldwide, and primary prevention efforts are poorly developed in people at high cardiovascular risk. On this background, we performed the Hjerteløftet Study and demonstrated that participation over 36 months in a multimodal primary prevention programme, significantly reduced validated cardiovascular risk scores. In the current substudy we aimed to further explore several elements and effects following the intervention programme.
METHODS METHODS
A random sample from the original Hjerteløftet Study was included for further examinations (n = 255, 40% women), and these patients were already randomized to an intervention group (IG) (n = 127), or a control group (CG) (n = 128). We compared changes from baseline to 36-months follow-up in physical activity, cardiorespiratory fitness, psychological well-being (WHO-5), cardiovascular medication use, smoking habits, and cardiometabolic risk factors (blood pressure, lipids, blood glucose, HbA1c, Apolipoprotein A-I, Apolipoprotein B and high-sensitive C-reactive protein).
RESULTS RESULTS
Self-reported physical activity increased significantly with absolute difference in mean delta Physical Activity Index score in the IG compared to the CG: 0.90, 95% CI: 0.10 to 1.70, p = 0.028 (ANCOVA). There were no corresponding differences in cardiorespiratory fitness. The participation resulted in psychological well-being improvement in both groups with a larger increase in the IG compared to the CG. The mean difference in delta WHO-5 score was 5.06, 95% CI: 0.68 to 9.45, p = 0.024, and 3.28, 95% CI: -0.69 to 5.25, p = 0.104 when controlled for baseline values (ANCOVA). The use of antihypertensive medication increased significantly more in the CG (p = 0.044). Only minor, nonsignificant changes were observed for traditional risk factors and cardiometabolic variables.
CONCLUSIONS CONCLUSIONS
Participation in the Hjerteløftet Study intervention programme resulted in an improved physical activity level, but without changing cardiorespiratory fitness. Participation in the programme also tended to improve psychological well-being, possibly related to increased physical activity, less smoking and less use of cardiovascular medication. Concerning the metabolic status, no major differences were observed, but minor changes may have been concealed by a larger increase in cardiovascular medication use in the control group.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov (NCT01741428), 04/12/2012.

Identifiants

pubmed: 38664620
doi: 10.1186/s12872-024-03892-1
pii: 10.1186/s12872-024-03892-1
doi:

Substances chimiques

Cardiovascular Agents 0

Banques de données

ClinicalTrials.gov
['NCT01741428']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

225

Informations de copyright

© 2024. The Author(s).

Références

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2021;42(34):3227–337. https://doi.org/10.1093/eurheartj/ehab484 .
doi: 10.1093/eurheartj/ehab484
Bergum H, Sandven I, Abdelnoor M, Anderssen SA, Grimsmo J, Rivrud DE, et al. Randomized trial of cardiovascular prevention in Norway combining an in-hospital lifestyle course with primary care follow-up: the Hjerteløftet study. Eur J Prev Cardiol. 2022;29(17):2252–63.
pubmed: 36124709 doi: 10.1093/eurjpc/zwac211
Kraus WE, Powell KE, Haskell WL, Janz KF, Campbell WW, Jakicic JM, et al. Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease. Med Sci Sports Exerc. 2019;51(6):1270–81.
pubmed: 31095084 pmcid: 6527136 doi: 10.1249/MSS.0000000000001939
Lavie CJ, Ozemek C, Carbone S, Katzmarzyk PT, Blair SN. Sedentary Behavior, Exercise, and Cardiovascular Health. Circ Res. 2019;124(5):799–815.
pubmed: 30817262 doi: 10.1161/CIRCRESAHA.118.312669
Letnes JM, Dalen H, Vesterbekkmo EK, Wisløff U, Nes BM. Peak oxygen uptake and incident coronary heart disease in a healthy population: the HUNT Fitness Study. Eur Heart J. 2019;40(20):1633–9.
pubmed: 30496487 doi: 10.1093/eurheartj/ehy708
Lee DC, Sui X, Artero EG, Lee IM, Church TS, McAuley PA, et al. Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the Aerobics Center Longitudinal Study. Circulation. 2011;124(23):2483–90.
pubmed: 22144631 pmcid: 3238382 doi: 10.1161/CIRCULATIONAHA.111.038422
Kubzansky LD, Huffman JC, Boehm JK, Hernandez R, Kim ES, Koga HK, et al. Positive psychological well-being and cardiovascular disease: JACC health promotion series. J Am Coll Cardiol. 2018;72(12):1382–96.
pubmed: 30213332 pmcid: 6289282 doi: 10.1016/j.jacc.2018.07.042
González-González JG, Violante-Cumpa JR, Zambrano-Lucio M, Burciaga-Jimenez E, Castillo-Morales PL, Garcia-Campa M, et al. HOMA-IR as a predictor of health outcomes in patients with metabolic risk factors: a systematic review and meta-analysis. High Blood Press Cardiovasc Prev. 2022;29(6):547–64.
pubmed: 36181637 doi: 10.1007/s40292-022-00542-5
Kaptoge S, Seshasai SR, Gao P, Freitag DF, Butterworth AS, Borglykke A, et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J. 2014;35(9):578–89.
pubmed: 24026779 doi: 10.1093/eurheartj/eht367
Norheim OF, Gjelsvik B, Klemsdal TO, Madsen S, Meland E, Narvesen S, et al. Norway’s new principles for primary prevention of cardiovascular disease: age differentiated risk thresholds. BMJ. 2011;343:d3626.
doi: 10.1136/bmj.d3626
Kurtze N, Rangul V, Hustvedt BE, Flanders WD. Reliability and validity of self-reported physical activity in the Nord-Trøndelag Health Study: HUNT 1. Scand J Public Health. 2008;36(1):52–61.
pubmed: 18426785 doi: 10.1177/1403494807085373
McClain JJ, Sisson SB, Tudor-Locke C. Actigraph accelerometer interinstrument reliability during free-living in adults. Med Sci Sports Exerc. 2007;39(9):1509–14.
pubmed: 17805082 doi: 10.1249/mss.0b013e3180dc9954
Troiano RP, Berrigan D, Dodd KW, Mâsse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2008;40(1):181–8.
pubmed: 18091006 doi: 10.1249/mss.0b013e31815a51b3
Topp CW, Ostergaard SD, Sondergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167–76.
pubmed: 25831962 doi: 10.1159/000376585
Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566–75.
pubmed: 20876408
Gysan DB, Millentrup S, Albus C, Bjarnason-Wehrens B, Latsch J, Gohlke H, et al. Substantial improvement of primary cardiovascular prevention by a systematic score-based multimodal approach: A randomized trial: The PreFord-Study. Eur J Prev Cardiol. 2017;24(14):1544–54.
pubmed: 28691508 doi: 10.1177/2047487317718081
Garcia-Lunar I, van der Ploeg HP, Fernández Alvira JM, van Nassau F, Castellano Vázquez JM, van der Beek AJ, et al. Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial. Eur Heart J. 2022;43(38):3732–45.
pubmed: 35869885 pmcid: 9553098 doi: 10.1093/eurheartj/ehac378
Helgerud J, Høydal K, Wang E, Karlsen T, Berg P, Bjerkaas M, et al. Aerobic high-intensity intervals improve VO2max more than moderate training. Med Sci Sports Exerc. 2007;39(4):665–71.
pubmed: 17414804 doi: 10.1249/mss.0b013e3180304570
Tjønna AE, Lee SJ, Rognmo Ø, Stølen TO, Bye A, Haram PM, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation. 2008;118(4):346–54.
pubmed: 18606913 pmcid: 2777731 doi: 10.1161/CIRCULATIONAHA.108.772822
Rognmo Ø, Hetland E, Helgerud J, Hoff J, Slørdahl SA. High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil. 2004;11(3):216–22.
pubmed: 15179103 doi: 10.1097/01.hjr.0000131677.96762.0c
Schjerve IE, Tyldum GA, Tjønna AE, Stølen T, Loennechen JP, Hansen HE, et al. Both aerobic endurance and strength training programmes improve cardiovascular health in obese adults. Clin Sci (Lond). 2008;115(9):283–93.
pubmed: 18338980 doi: 10.1042/CS20070332
Prince SA, Dempsey PC, Reed JL, Rubin L, Saunders TJ, Ta J, et al. The Effect of Sedentary Behaviour on Cardiorespiratory Fitness: A Systematic Review and Meta-Analysis. Sports Med. 2024.
Letnes JM, Dalen H, Aspenes ST, Salvesen Ø, Wisløff U, Nes BM. Age-related change in peak oxygen uptake and change of cardiovascular risk factors. The HUNT Study Prog Cardiovasc Dis. 2020;63(6):730–7. https://doi.org/10.1016/j.pcad.2020.09.002 .
doi: 10.1016/j.pcad.2020.09.002
Moore SC, Patel AV, Matthews CE, de Gonzalez AB, Park Y, Katki HA, et al. Leisure time physical activity of moderate to vigorous intensity and mortality a large pooled cohort analysis. PLoS Med. 2012;9(11):e1001335.
pubmed: 23139642 pmcid: 3491006 doi: 10.1371/journal.pmed.1001335
Löllgen H, Böckenhoff A, Knapp G. Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. Int J Sports Med. 2009;30(3):213–24.
pubmed: 19199202 doi: 10.1055/s-0028-1128150
Lee DC, Pate RR, Lavie CJ, Sui X, Church TS, Blair SN. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol. 2014;64(5):472–81.
pubmed: 25082581 pmcid: 4131752 doi: 10.1016/j.jacc.2014.04.058
Garcia L, Pearce M, Abbas A, Mok A, Strain T, Ali S, et al. Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies. Br J Sports Med. 2023;57(15):979–89. https://doi.org/10.1136/bjsports-2022-105669 .
doi: 10.1136/bjsports-2022-105669 pubmed: 36854652
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56–528.
pubmed: 30700139 doi: 10.1161/CIR.0000000000000659
Ekelund U, Steene-Johannessen J, Brown WJ, Fagerland MW, Owen N, Powell KE, et al. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet. 2016;388(10051):1302–10.
pubmed: 27475271 doi: 10.1016/S0140-6736(16)30370-1
Wu Z, Huang Z, Wu Y, Huang S, Wang Y, Zhao H, et al. Sedentary time, metabolic abnormalities, and all-cause mortality after myocardial infarction: A mediation analysis. Eur J Prev Cardiol. 2019;26(1):96–104.
pubmed: 30289271 doi: 10.1177/2047487318804611
Healy GN, Winkler EA, Owen N, Anuradha S, Dunstan DW. Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers. Eur Heart J. 2015;36(39):2643–9.
pubmed: 26228867 doi: 10.1093/eurheartj/ehv308
Ekelund U, Tarp J, Steene-Johannessen J, Hansen BH, Jefferis B, Fagerland MW, et al. Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis. BMJ. 2019;366:l4570.
pubmed: 31434697 pmcid: 6699591 doi: 10.1136/bmj.l4570
Hansen BH, Kolle E, Steene-Johannessen J, Dalene KE, Ekelund U, Anderssen SA. Monitoring population levels of physical activity and sedentary time in Norway across the lifespan. Scand J Med Sci Sports. 2019;29(1):105–12.
pubmed: 30276928 doi: 10.1111/sms.13314
Edvardsen E, Hansen BH, Holme IM, Dyrstad SM, Anderssen SA. Reference values for cardiorespiratory response and fitness on the treadmill in a 20- to 85-year-old population. Chest. 2013;144(1):241–8.
pubmed: 23287878 doi: 10.1378/chest.12-1458
Dunstan DW, Dogra S, Carter SE, Owen N. Sit less and move more for cardiovascular health: emerging insights and opportunities. Nat Rev Cardiol. 2021;18(9):637–48.
pubmed: 34017139 doi: 10.1038/s41569-021-00547-y
Dale H, Brassington L, King K. The impact of healthy lifestyle interventions on mental health and wellbeing a systematic review. Mental Health Rev J. 2014;19(1):1–26.
doi: 10.1108/MHRJ-05-2013-0016
Kim ES, Kubzansky LD, Soo J, Boehm JK. Maintaining healthy behavior: a prospective study of psychological well-being and physical activity. Ann Behav Med. 2017;51(3):337–47.
pubmed: 27822613 doi: 10.1007/s12160-016-9856-y
Boehm JK, Vie LL. The promise of well-being interventions for improving helath risk behaviors. Curr Cardiovasc Risk Rep. 2012;6:511–9.
doi: 10.1007/s12170-012-0273-x
Stevens M, Lieschke J, Cruwys T, Cárdenas D, Platow MJ, Reynolds KJ. Better together: How group-based physical activity protects against depression. Soc Sci Med. 2021;286:114337.
pubmed: 34450391 doi: 10.1016/j.socscimed.2021.114337
Boehm JK, Kubzansky LD. The heart’s content: the association between positive psychological well-being and cardiovascular health. Psychol Bull. 2012;138(4):655–91.
pubmed: 22506752 doi: 10.1037/a0027448
Pressman SD, Jenkins BN, Moskowitz JT. Positive Affect and Health: What Do We Know and Where Next Should We Go? Annu Rev Psychol. 2019;70:627–50.
pubmed: 30260746 doi: 10.1146/annurev-psych-010418-102955
Trudel-Fitzgerald C, Millstein RA, von Hippel C, Howe CJ, Tomasso LP, Wagner GR, et al. Psychological well-being as part of the public health debate? Insight into dimensions, interventions, and policy. BMC Public Health. 2019;19(1):1712.
pubmed: 31856772 pmcid: 6923969 doi: 10.1186/s12889-019-8029-x
Bergum H, Sandven I, Klemsdal TO. Long-term effects (> 24 months) of multiple lifestyle intervention on major cardiovascular risk factors among high-risk subjects: a meta-analysis. BMC Cardiovasc Disord. 2021;21(1):181.
pubmed: 33858345 pmcid: 8048075 doi: 10.1186/s12872-021-01989-5
Taylor GM, Lindson N, Farley A, LeinbergerJabari A, Sawyer K, Te Water Naudé R, et al. Smoking cessation for improving mental health. Cochrane Database Syst Rev. 2021;3(3):Cd013522.
pubmed: 33687070
Prince SA, Adamo KB, Hamel ME, Hardt J, Connor Gorber S, Tremblay M. A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review. Int J Behav Nutr Phys Act. 2008;5:56.
pubmed: 18990237 pmcid: 2588639 doi: 10.1186/1479-5868-5-56
Warren JM, Ekelund U, Besson H, Mezzani A, Geladas N, Vanhees L. Assessment of physical activity - a review of methodologies with reference to epidemiological research: a report of the exercise physiology section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17(2):127–39.
pubmed: 20215971 doi: 10.1097/HJR.0b013e32832ed875
Clark BK, Lynch BM, Winkler EA, Gardiner PA, Healy GN, Dunstan DW, et al. Validity of a multi-context sitting questionnaire across demographically diverse population groups: AusDiab3. Int J Behav Nutr Phys Act. 2015;12:148.
pubmed: 26637392 pmcid: 4670496 doi: 10.1186/s12966-015-0309-y

Auteurs

Hilde Bergum (H)

Department of Cardiac and Pulmonary Rehabilitation, Lovisenberg Rehabilitation, Cathinka Guldbergs Hospital, Jessheim, 2051, Norway. hilde.marie.bergum@lovisenberg.no.
University of Oslo, Oslo, Norway. hilde.marie.bergum@lovisenberg.no.

Jostein Grimsmo (J)

Department of Cardiac and Pulmonary Rehabilitation, Lovisenberg Rehabilitation, Cathinka Guldbergs Hospital, Jessheim, 2051, Norway.

Sigmund Alfred Anderssen (SA)

Department of Sports Medicine, the Norwegian School of Sports Sciences, Sognsveien 220, 0806, Oslo, Norway.

Tor Ole Klemsdal (TO)

Department of Preventive Cardiology, Oslo University Hospital Aker, Trondheimsveien 235, 0586, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH